Radioactive iodine treatment for low-risk thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at how well radioactive iodine therapy works for patients with certain types of thyroid cancer that are considered low or intermediate risk. It may help you understand if this treatment is right for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of thyroid cancer called differentiated thyroid cancer (like papillary or follicular).
- You had surgery to remove your whole thyroid gland (total thyroidectomy), with or without removing nearby lymph nodes.
- You already received radioactive iodine treatment after your surgery.
- You are 18 years old or older.
- You do not have other high-risk conditions, such as cancer that has spread to other parts of the body, a different type of cancer (like medullary or undifferentiated thyroid cancer), or another separate cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches after thyroid surgery: giving radioactive iodine right away versus deciding based on follow-up test results. It aims to see which approach better helps people with intermediate-risk differentiated thyroid cancer.
This study looks at how different doses of radioactive iodine work for people with papillary or follicular thyroid cancer after their thyroid has been removed. It aims to find the best dose to treat the cancer while reducing side effects.
This trial is testing whether giving radiation therapy after thyroid surgery can help destroy any leftover cancer cells in people with high-risk differentiated thyroid cancer. It is for those who had surgery but some cancer was still left behind.
This trial offers a decision aid to help you choose whether to have radioactive iodine (RAI) treatment after thyroid cancer surgery. You may qualify if you have intermediate-risk thyroid cancer and haven't yet made a decision about RAI.
This study looks at how well thyroid hormone replacement works after radioactive iodine treatment for high-risk thyroid cancer. It may help find the best way to manage your hormone levels after treatment.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.